Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales

Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q1 EPS of $1.64, $0.04 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.52 million versus the consensus estimate of $1.48 million.

Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.

For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Marlin Business Services (MRLN) Reports Q2 Loss of $1.40
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c